GHRP-6 - 5mg

GHRP-6 - 5mg

€29.00
Tax excluded
QuantityUnit priceYou Save
10€24.65Up to €43.50
20€20.88Up to €162.40
50€17.40Up to €580.00
100€15.08Up to €1,392.00
200€13.05Up to €3,190.00

The minimum purchase order quantity for the product is 5.

 IN-STOCK

This product is part of our high-demand compounds and is supplied on this store in bulk quantities. For individual purchases, this product is also available on our secondary store.



No additional shipping fees will be applied. Item ordered from both stores will be shipped together in a single delivery.

GHRP-6 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and neuroendocrine communication processes.

Due to its well-characterized receptor activity, GHRP-6 remains a compound of interest in experimental models investigating ghrelin-related signaling and growth hormone regulatory pathways.

Description

SPECIFICATIONS

Product Code: GR6005

Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys

Molecular Formula: C46H56N12O6

Molecular Weight: 873.032 g/mol

CAS: 87616-84-0

Purity: Technical / Research Grade 98%

Other details: No TFA Salt

Form: Lyophilized powder

Color: White

Storage temperature: -20°C

Source: Synthetic

Safety classification: Standard handling

DESCRIPTION

GHRP-6 (Growth Hormone–Releasing Peptide-6) is a synthetic hexapeptide that functions as a selective agonist of the ghrelin receptor (GHS-R1a). It is structurally related to other growth hormone secretagogues and is widely used in experimental research environments. In laboratory models, GHRP-6 is studied for its interaction with receptor-mediated signaling pathways associated with endocrine regulation and neuroendocrine communication. Its activity is linked to ghrelin receptor signaling mechanisms involved in system-wide physiological coordination.

Activation of GHS-R1a receptors by GHRP-6 initiates intracellular signaling cascades associated with cellular communication, regulatory processes, and endocrine pathway coordination. These signaling mechanisms are studied to better understand the integration between neuroendocrine and metabolic systems. GHRP-6 is also investigated in research contexts focused on signaling interactions between central and peripheral regulatory pathways, including those involved in endocrine communication and system-wide biological responses.

Due to its defined receptor activity and well-characterized signaling profile, GHRP-6 remains a relevant compound in experimental models exploring ghrelin-associated pathways and growth hormone–related signaling mechanisms.

REFERENCES

All observations described above originate from in vitro systems, animal studies, or other preclinical experimental models. They are intended solely to support basic research into molecular, cellular, and physiological mechanisms and do not imply therapeutic, diagnostic, or preventive applications in humans or animals.

T.Lei et al., "Growth hormone releasing peptide (GHRP-6) stimulates phosphatidylinositol (PI) turnover in human pituitary somatotroph cells" [PubMed]

A. Lania et al., "Growth hormone-releasing hexapeptide (GHRP-6) increases intracellular calcium concentrations in cultured cells from human pituitary adenomas of different types" [PubMed]

R.J. DeVita "Small molecule mimetics of GHRP-6" [PubMed]

M.H. Borges et al., "Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism" [PubMed]

V. Popovic et al., "Evaluation of pituitary GH reserve with GHRP-6" [PubMed]

F.R. Pimentel-Filho et al., "Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism" [PubMed]

R.M. Frieboes et al., "Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man" [PubMed]

K.m. Fairhall et al., "Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action" [PubMed]

DISCLAIMER

This product is intendend for lab research and development use only. These studies are performed outside of the body. This product is not medicines or drugs and has not been approved by the FDA or EMA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals.

All product information provided on this website is for informational and educational purposes only.

Data sheet

GR6005

Customers who bought this product also bought:

ImageRef.Unit priceWeightAvail.Buy
GHRP-6 - 5mg
GR6005
€29.00
Discount by quantity
10+
€24.65
–15%
20+
€20.88
–28%
50+
€17.40
–40%
100+
€15.08
–48%
200+
€13.05
–55%
0.000000 kg
Min.: 5
Total: 0,0
All prices with tax included.
 Product is available
 Product is no longer in stock
 Product is no in stock, but is allowed to be back-ordered